BAY-1251152
- Product Name
- BAY-1251152
- CAS No.
- 1610358-56-9
- Chemical Name
- BAY-1251152
- Synonyms
- BAY-1251152;(+)-BAY-1251152;(+)-Enitociclib;(±)-BAY-1251152;BAY 1251152 ，S8730;Enitociclib (BAY 1251152);(+)Enitociclib,(+) Enitociclib;BAY 1251152 ((+)-BAY 1251152 );(+)-5-fluoro-4-(4-fluoro-2-methoxy-phenyl)-N-[4-[(methylsulfonimidoyl)methyl]-2-pyridyl]pyridin-2-amine;(+)-5-Fluoro-4-(4-fluoro-2-methoxyphenyl)-N-(4-((S-methylsulfonimidoyl)methyl)pyridin-2-yl)pyridin-2-amine
- CBNumber
- CB93364607
- Molecular Formula
- C19H18F2N4O2S
- Formula Weight
- 404.43
- MOL File
- 1610358-56-9.mol
BAY-1251152 Property
- Boiling point:
- 494.2±55.0 °C(Predicted)
- Density
- 1.36±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- DMSO:97.15(Max Conc. mg/mL);240.21(Max Conc. mM)
- form
- Solid
- color
- Off-white to yellow
N-Bromosuccinimide Price
- Product number
- B119025
- Product name
- (+)-BAY-1251152
- Packaging
- 1mg
- Price
- $225
- Updated
- 2021/12/16
- Product number
- CS-0023124
- Product name
- (+)-BAY-1251152
- Purity
- 99.66%
- Packaging
- 5mg
- Price
- $228
- Updated
- 2021/12/16
- Product number
- CS-0023124
- Product name
- (+)-BAY-1251152
- Purity
- 99.66%
- Packaging
- 10mg
- Price
- $348
- Updated
- 2021/12/16
- Product number
- CS-0023124
- Product name
- (+)-BAY-1251152
- Purity
- 99.66%
- Packaging
- 50mg
- Price
- $1068
- Updated
- 2021/12/16
- Product number
- CS-0023124
- Product name
- (+)-BAY-1251152
- Purity
- 99.66%
- Packaging
- 2mg
- Price
- $132
- Updated
- 2021/12/16
BAY-1251152 Chemical Properties,Usage,Production
Uses
(+)-Enitociclib ((+)-BAY-1251152) is an enanthiomer of BAY-1251152 with rotation (+). Enitociclib is a potent and selective CDK9 inhibitor with an IC50 of 3 nM. Enitociclib has anti-tumour activity[1][2].
in vivo
(+)-Enitociclib (Compound A’; 10 mg/kg; intravenous injection; once every seven days; for 14 days; female SCID mice) reaches a Treatment to Control ratios (T/C) by area of 0.29 and a T/C by weight of 0.24. Enitociclib inhibits tumour growth and had good tolerability[2].
| Animal Model: | Female SCID mice with OCI-LY-3 cells[2] |
| Dosage: | 10 mg/kg |
| Administration: | Intravenous injection; once every seven days; for 14 days |
| Result: | Inhibited tumour growth and had good tolerability. |
IC 50
CDK9/CycT1: 3 nM (IC50)
References
[1] Ulrich LüCKING, et al. 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group. WO2014076091A1.
[2] Use of Arne Scholz, et al. 5-fluoro-4-(4-fluoro-2-methoxyphenyl)-n-{4-[(s-methylsulfonimidoyl)methyl]pyridin-2-yl}pyridin-2-amine for treating diffuse large b-cell lymphoma. WO2019158517A1.
BAY-1251152 Preparation Products And Raw materials
Raw materials
Preparation Products
BAY-1251152 Suppliers
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
- Country
- United States
- ProdList
- 12952
- Advantage
- 65
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
- Country
- United States
- ProdList
- 32435
- Advantage
- 58
- Tel
- +1-708-310-1919 +1-13798911105
- Fax
- 708-557-7486
- sales@invivochem.cn
- Country
- United States
- ProdList
- 6391
- Advantage
- 58
- Tel
- tp@aladdinsci.com
- Country
- United States
- ProdList
- 57505
- Advantage
- 58
- Tel
- --
- Fax
- --
- sales@advtechind.com
- Country
- United States
- ProdList
- 6075
- Advantage
- 58